longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ORCS

ORCS
----

LongbridgeAI

Weekly Recap | Oracle -5.35%, most brokers rate it buy

Weekly Review
Sep 12, 2026 at 06:34 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Oracle (ORCL) fell 5.35% for the week to close at $150.28, trailing the S&P 500, which lost 0.8%, by roughly 4.55 percentage points. The move played out as a fade from the opening gap: Tuesday (Sep 8) opened at $167.60 and printed a high of $170.70, then slid through the next two sessions. Friday (Sep 11) saw an intraday low of $149.84 before a partial recovery. The weekly range stood at 12.45%, and average daily volume of about 50.6m shares ran roughly 60% above the 60-day median.

The Week

Oracle (ORCL) fell 5.35% for the week to close at $150.28, trailing the S&P 500, which lost 0.8%, by roughly 4.55 percentage points. The move played out as a fade from the opening gap: Tuesday (Sep 8) opened at $167.60 and printed a high of $170.70, then slid through the next two sessions. Friday (Sep 11) saw an intraday low of $149.84 before a partial recovery. The weekly range stood at 12.45%, and average daily volume of about 50.6m shares ran roughly 60% above the 60-day median.

Key Events

The focal point was Oracle’s fiscal Q1 2027 earnings release. Concerns about AI spending were partly addressed as cloud infrastructure revenue grew 121%, and AI-driven backlog growth helped ease worries about the payoff from data-centre buildouts. After the release, the stock jumped nearly 7% after hours, but Friday trading was choppy: shares initially rose 6%, then pulled back to about 3% by the close, leaving the stock down for the week.

Two other items sat alongside the earnings window. Oracle disclosed an additional $700m in restructuring costs tied to layoffs, bringing expected job-cut spending to $2.8bn, while founder Larry Ellison adopted a trading plan to sell up to $7.5bn worth of stock. Both landed as secondary layers of pressure during the week.

Analyst Ratings

Coverage on Oracle stands at 46 firms: 27 rate buy, 8 rate over, 7 rate hold, 1 rate sell, and 3 have no opinion. The consensus recommendation is buy, with a consensus target of $239.10, roughly 59.1% above the $150.28 close. The spread between the $400 high target and $110 low target points to genuine disagreement about the timing of AI returns. Oracle ranks 5th among 47 names in the system software group.

The Week Ahead

Three threads matter next week. First is how the stock digests its post-earnings fade: the turn lower into Friday’s close sets up Monday (Sep 15) as a test of how investors weigh 121% cloud infrastructure growth against layoff costs and Ellison’s share sale plan. Second, the macro calendar brings the Empire State manufacturing index on Tuesday (Sep 15) and a cluster of retail sales prints on Wednesday (Sep 16), with weak consumption data potentially pressuring the AI-cycle narrative. Third, Oracle’s $300bn OpenAI partnership was a recurring theme in this week’s coverage, and any fresh order flow or capacity updates would add a company-specific catalyst.

In Short

The tension this week is clear: a consensus target 59.1% above spot, most brokers rating it buy, and 121% cloud infrastructure growth all point upward, yet the stock fell 5.35% and trailed the S&P 500 by 4.55 percentage points, with layoff charges and a sizeable founder sale adding pressure. Valuation is not cheap at about 23.1x earnings and 6.44x book, and the latest session shows large-lot money as a net seller. The question ahead is whether AI backlog growth can convert into steadier share-price performance, and how macro data after Sep 15 reshapes the risk backdrop.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock2,590characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Oracle

Oracle

USORCL

+3.20%

ORCL 2X Long ETF

ORCL 2X Long ETF

USORCX

Direxion Daily ORCL Bull 2X ETF

Direxion Daily ORCL Bull 2X ETF

USORCU